CD4+ Tregs and immune control

被引:324
作者
Fehérvari, Z
Sakaguchi, S
机构
[1] Kyoto Univ, Inst Frontier Med Sci, Dept Expt Pathol, Sakyo Ku, Kyoto 6068507, Japan
[2] RIKEN, Inst Phys & Chem Res, Immunopathol Lab, Res Ctr Allergy & Immunol, Yokohama, Kanagawa, Japan
[3] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Japan
关键词
D O I
10.1172/JCI200434495
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Recent years have seen Tregs become a popular subject of immunological research. Abundant experimental data have now confirmed that naturally occurring CD25(+)CD4(+) Tregs in particular play a key role in the maintenance of self tolerance, with their dysfunction leading to severe or even fatal immunopathology. The sphere of influence of Tregs is now known to extend well beyond just the maintenance of immunological tolerance and to impinge on a host of clinically important areas from cancer to infectious diseases. The identification of specific molecular markers in both human and murine immune systems has enabled the unprecedented investigation of these cells and should prove key to ultimately unlocking their clinical potential.
引用
收藏
页码:1209 / 1217
页数:9
相关论文
共 113 条
  • [91] Human CD25+ regulatory T cells:: two subsets defined by the integrins α4β7 or α4β1 confer distinct suppressive properties upon CD4+ T helper cells
    Stassen, M
    Fondel, S
    Bopp, T
    Richter, C
    Müller, C
    Kubach, J
    Becker, C
    Knop, J
    Enk, AH
    Schmitt, S
    Schmitt, E
    Jonuleit, H
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (05) : 1303 - 1311
  • [92] Tolerogenic dendritic cells
    Steinman, RM
    Hawiger, D
    Nussenzweig, MC
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 2003, 21 : 685 - 711
  • [93] Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+ CD25+ T cells
    Stephens, GL
    McHugh, RS
    Whitters, MJ
    Young, DA
    Luxenberg, D
    Carreno, BM
    Collins, M
    Shevach, EM
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 173 (08) : 5008 - 5020
  • [94] Decreasing the threshold for thymocyte activation biases CD4+ T cells toward a regulatory (CD4+CD25+) lineage
    Stephens, GL
    Ignatowicz, L
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (05) : 1282 - 1291
  • [95] Differential cytokine requirements for regulation of autoimmune gastritis and colitis by CD4+CD25+ T cells
    Suri-Payer, E
    Cantor, H
    [J]. JOURNAL OF AUTOIMMUNITY, 2001, 16 (02) : 115 - 123
  • [96] Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25+ regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses
    Sutmuller, RPM
    van Duivenvoorde, LM
    van Elsas, A
    Schumacher, TNM
    Wildenberg, ME
    Allison, JP
    Toes, REM
    Offringa, R
    Melief, CJM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (06) : 823 - 832
  • [97] Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells:: induction of autoimmune disease by breaking their anergic/suppressive state
    Takahashi, T
    Kuniyasu, Y
    Toda, M
    Sakaguchi, N
    Itoh, M
    Iwata, M
    Shimizu, J
    Sakaguchi, S
    [J]. INTERNATIONAL IMMUNOLOGY, 1998, 10 (12) : 1969 - 1980
  • [98] Immunologic self-tolerance maintained by CD25+CD4+ regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4
    Takahashi, T
    Tagami, T
    Yamazaki, S
    Uede, T
    Shimizu, J
    Sakaguchi, N
    Mak, TW
    Sakaguchi, S
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (02) : 303 - 309
  • [99] Cutting edge:: IL-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function
    Thornton, AM
    Donovan, EE
    Piccirillo, CA
    Shevach, EM
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 172 (11) : 6519 - 6523
  • [100] CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production
    Thornton, AM
    Shevach, EM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (02) : 287 - 296